Bioresorbable medical devices
OwnerBalkrishna S. Jadhav, Robert C. Grantinventors
Life of this patent
Estimating the term…
Abstract
A bio-compatible and bioresorbable medical device is disclosed. Specifically a polymeric stent is disclosed intended to restore or maintain patency following surgical procedures, traumatic injury or stricture formation. The polymeric stent is composed of one or more polymers that is either extruded as a monofilament then woven into a braid-like embodiment, or injection molded or extruded as a tube with fenestrations in the wall. Related methods for controlling the medical devices' in vivo functional life by controlling polymer monomer content and other polymer structural qualities are also provided.
Claims31
A method for controlling a polymeric stent's in vivo functional life span comprising:
- selecting a bioresorbable, biocompatible polymer composition,
- determining a monomer content within said bioresorbable, biocompatible polymer composition,
- adjusting said monomer content in said bioresorbable, biocompatible polymer to within a predetermined range.
A method for controlling bioresorbable stent in vivo functional life wherein said stent comprises a polymeric composition having monomer content within a predetermined range comprising:
- adjusting said monomer content to within said predetermined range in said polymeric composition prior to stent formation using a method selected from the group consisting of polymer extrusion pressure and temperature, blending polymeric ingredients, having differing monomer content, adding monomer to said polymeric composition and combinations thereof.
A method of producing a bioresorbable, polymeric stent comprising:
- providing biocompatible, bioresorbable polymeric monofilaments wherein said polymeric monofilaments comprise a polymeric composition adjusted to have a monomer content within a predetermined range;
- braiding said monofilaments into a latticed network, said latticed network having an alternating braiding pattern;
- and
- annealing said latticed structure.
A method of producing a bioresorbable, polymeric stent comprising:
- selecting a bioresorbable, biocompatible polymer composition,
- determining a monomer content within said bioresorbable, biocompatible polymer composition,
- adjusting said monomer content in said bioresorbable, biocompatible polymer to within a predetermined range,
- extruding said polymer composition Into monofilaments,
- braiding said monofilaments into a latticed structure, wherein said biocompatible, bioresorbable monofilaments are woven in an alternating braiding pattern;
- and
- annealing said latticed structure in an inert atmosphere wherein said inert atmosphere is selected from the group consisting of nitrogen, argon, helium, and high vacuum.
A method of producing a bioresorbable, self-expanding stent comprising:
- (a) selecting a high molecular weight poly-L-lactic acid (PLLA) polymeric composition,
- (b) determining a monomer content within PLLA;
- (c) adjusting said monomer content in said PLLA to within a predetermined range;
- (d) extruding said PLLA into monofilaments;
- (e) braiding said poly-L-lactide monofilaments into a latticed structure, wherein said poly-L-lactide monofilaments are woven in an alternating under-two-over-two pattern;
- (f) axially compressing said latticed structure on a mandrel by 30% to 60%
- (g) annealing said latticed structure at approximately 90° C. for at least one hour in an inert atmosphere, wherein said inert atmosphere is selected from the group consisting of nitrogen, argon, helium, and high vacuum;
- and
- (h) exposing said latticed structure to approximately 35 kGy to 75 kGy total dose of gamma irradiation.
A method of producing a stent comprising:
- selecting a bioresorbable, biocompatible polymer composition,
- determining a monomer content within said bioresorbable, biocompatible polymer composition,
- adjusting said monomer content in said bioresorbable, biocompatible polymer to within a predetermined range,
- forming a tubular sheath having fenestrations from said biocompatible, bioresorbable polymer;
- and
- annealing said tubular sheath.
The method according to 22 wherein said annealing step further comprises heating said tubular sheath for approximately one to three hours.
A method of producing a stent comprising:
- selecting a bioresorbable, biocompatible polymer composition,
- determining a monomer content within said bioresorbable, biocompatible polymer composition,
- adjusting said monomer content in said bioresorbable, biocompatible polymer to within a predetermined range,
- forming a tubular sheath from a biocompatible, bioresorbable polymer;
- cutting fenestrations into said tubular sheath;
- and
- annealing said tubular sheath for approximately one to three hours in an inert atmosphere.
A bioresorbable, self-expanding stent comprising:
- a cylindrical sleeve having a first end and a second end;
- a latticed network disposed between said first end and said second end of said cylindrical sleeve;
- said latticed network formed from approximately forty monofilaments helically wound about a longitudinal axis of said cylindrical sleeve, wherein approximately twenty of said monofilaments are wound in a clockwise direction and approximately twenty said monofilaments are wound in a counter-clockwise direction, wherein said approximately forty monofilaments are braided in an alternating under-two-over-two braid pattern;
- and
- said plurality of braided monofilaments comprises a PLLA composition wherein said PLLA composition has a monomer content adjusted such that said PLLA composition has a controllable in vivo lifetime.
Dependencies are inferred from the claim text.